Applications of calixarenes in cancer chemotherapy: facts and perspectives - Wikidata - wikimedia - TriplyDB

Applications of calixarenes in cancer chemotherapy: facts and perspectives

Applications of calixarenes in cancer chemotherapy: facts and perspectives

http://www.wikidata.org/entity/Q26995815

about

Binding abilities of a chiral calix[4]resorcinarene: a polarimetric investigation on a complex case of study.Synthesis, in-Vitro and in Silico Studies of Azo-Based Calix[4]arenes as Antibacterial Agent and Neuraminidase Inhibitor: A New Look Into an Old Scaffold.

P2860

Q52347040-B2D11E14-344E-40AE-A2FE-F2FCA3F93FF0 Q55395346-5870BBC3-224F-4C9D-AF56-6832154F857A

P2860

Applications of calixarenes in cancer chemotherapy: facts and perspectives

http://www.wikidata.org/entity/Q26995815

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Applications of calixarenes in cancer chemotherapy: facts and perspectives

@ast

Applications of calixarenes in cancer chemotherapy: facts and perspectives

@en

Applications of calixarenes in cancer chemotherapy: facts and perspectives

@nl

type

label

Applications of calixarenes in cancer chemotherapy: facts and perspectives

@ast

Applications of calixarenes in cancer chemotherapy: facts and perspectives

@en

Applications of calixarenes in cancer chemotherapy: facts and perspectives

@nl

prefLabel

Applications of calixarenes in cancer chemotherapy: facts and perspectives

@ast

Applications of calixarenes in cancer chemotherapy: facts and perspectives

@en

Applications of calixarenes in cancer chemotherapy: facts and perspectives

@nl

P1433

Q26995815-1BF29449-6C17-4400-9008-3BBF665B40B5

P1476

Q26995815-80C21C34-AA2D-40CC-B7DF-E2B3DC1D692F

P2093

Q26995815-9D3A004D-79A9-4587-93EC-E9D75536506A

Q26995815-A173B9B1-E5BF-4109-9854-93E8D52D0ED5

Q26995815-AF8E4DF6-3B20-4F81-8A01-139E6E109FA8

Q26995815-B9469744-81E4-4859-8529-C6A12157F05F

P275

Q26995815-EDA7B920-E711-4959-8586-35CAB97E7C03

P2860

Q26995815-066817AC-7371-484C-87B6-C05829FC26FF

Q26995815-16437F3D-7A2E-4FBD-8CB2-59298BD223BA

Q26995815-19337E66-7505-49A7-83C4-EE21778FA937

Q26995815-1EFF592D-0A36-4210-A55B-4F5F639E5AF4

Q26995815-2C8B310E-1024-47D1-84D9-BD212C720586

Q26995815-373C79B3-8709-4599-9748-2EEFB81A1DE6

Q26995815-46042382-FD39-4BF6-BBA0-D8515BF273C2

Q26995815-46CA71D5-08FD-46CF-81A5-0D58E269481A

Q26995815-47666293-1E80-4E47-B9FD-0DF0477C2171

Q26995815-5192A31C-D609-4657-AB71-DA8E519F36E6

P304

Q26995815-1BB1AB6B-13D8-4A45-BFC0-B4F5B0B641CA

P31

Q26995815-0655018D-8033-470A-8544-90C0F5C5C1B8

Q26995815-1B440B81-F8C2-421E-B7B2-3B07319B5156

P356

Q26995815-F35295B4-267B-4A55-B511-5BA12E8F0375

P407

Q26995815-B877C20C-6064-41E3-812C-B82844D18A2B

P478

Q26995815-68241D92-35AB-4B55-B687-DC1F0E60B8AA

P5008

Q26995815-DE518837-A47F-410C-8E19-D60BC6D032C3

P577

Q26995815-2B28F1E6-FBA3-4D79-BC0E-B99E672EF70F

Q26995815-CF0652BB-A58C-4CC6-972E-7A5B8D8DFEB5

P698

Q26995815-B268AE2E-028E-48E1-ABFC-AA0B76CE3BF9

P921

Q26995815-29860E4B-A5C9-4E57-8967-F9F0480099CF

Q26995815-8D18820F-BED7-4E08-BC63-46F0348928BB

Q26995815-FBC5A2D5-B388-4846-B866-42FA7B6B8422

P932

Q26995815-51C7FABE-E57F-4371-B217-295F1C16E7B6

P356

P1433

Drug Design, Development and Therapy

P1476

Applications of calixarenes in cancer chemotherapy: facts and perspectives

@en

P2093

Ishola Afeez Adekunle

http://www.w3.org/2001/XMLSchema#string

Noraslinda M Bunnori

http://www.w3.org/2001/XMLSchema#string

Shafida Abd Hamid

http://www.w3.org/2001/XMLSchema#string

Yousaf Ali

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Efficient synthesis of water-soluble calixarenes using click chemistry.

An update on photodynamic therapy applications.

Structure-activity studies on a library of potent calix[4]arene-based PDGF antagonists that inhibit PDGF-stimulated PDGFR tyrosine phosphorylation.

Design of nonpeptidic topomimetics of antiangiogenic proteins with antitumor activities.

The Rule of Five revisited: applying log D in place of log P in drug-likeness filters.

Causes and consequences of tumour acidity and implications for treatment.

Photodynamic therapy for cancer.

Amphoteric calix[8]arene-based complex for pH-triggered drug delivery.

The present and future role of photodynamic therapy in cancer treatment.

Polycationic calixarene PTX013, a potent cytotoxic agent against tumors and drug resistant cancer.

P304

2831-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S83213

http://www.w3.org/2001/XMLSchema#string

P407

P478

9

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2015-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26082613

http://www.w3.org/2001/XMLSchema#string

P921

polycyclic compound

P932

4459628

http://www.w3.org/2001/XMLSchema#string